Correspondence | Published:

Response to 'Amplifying Igh translocations'

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Potter, M. Hematol. Oncol. Clin. North Am. 11, 323–347 (1997).

  2. 2

    Potter, M. Immunol. Rev. 194, 177–195 (2003).

  3. 3

    Ramiro, A.R. et al. Cell 118, 431–438 (2004).

  4. 4

    Unniraman, S., Zhou, S. & Schatz, D.G. Nat. Immunol. 5, 1117–1123 (2004).

  5. 5

    Muller, J.R., Jones, G.M., Janz, S. & Potter, M. Blood 89, 291–296 (1997).

  6. 6

    Muller, J.R., Jones, G.M., Potter, M. & Janz, S. Cancer Res. 56, 419–423 (1996).

  7. 7

    Kovalchuk, A.L. et al. Proc. Natl. Acad. Sci. USA 99, 1509–1514 (2002).

  8. 8

    Kovalchuk, A.L., Muller, J.R. & Janz, S. Oncogene 15, 2369–2377 (1997).

  9. 9

    Kovalchuk, A.L., Kishimoto, T. & Janz, S. Leukemia 14, 1127–1135 (2000).

  10. 10

    Janz, S., Muller, J., Shaughnessy, J. & Potter, M. Proc. Natl. Acad. Sci. USA 90, 7361–7365 (1993).

  11. 11

    Roschke, V., Kopantzev, E., Dertzbaugh, M. & Rudikoff, S. Oncogene 14, 3011–3016 (1997).

Download references

Author information

Correspondence to David G Schatz.

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Publication history

  • Issue Date

DOI

https://doi.org/10.1038/ni0205-118

Figure 1: PCR and Southern blot assays of samples from Rag1−/− mice as well as positive and negative controls.